Skip to main content

CSL

CSL Limited is an Australian global biotechnology company specializing in plasma-derived therapies, vaccines, and iron deficiency treatments. The enterprise operates through three core business segments: CSL Behring, CSL Seqirus, and CSL Vifor. Its product portfolio includes plasma therapies for rare diseases, cell-based influenza vaccines, recombinant coagulation factors, and iron management pharmaceuticals. Revenue is driven by product distribution to healthcare providers, hospitals, and government immunization programs worldwide. The company holds a market-leading global position in plasma collection, immunoglobulin manufacturing, and influenza prevention. CSL Limited is headquartered in Melbourne, Australia, and listed on the Australian Securities Exchange.

34 of the funds FundTelligence covers report a position in CSL.

Legal name
CSL Ltd
Sector
Health Care
Country
Australia
Funds holding it
34

Funds holding CSL

Showing the 8 largest of 34 funds holding it.

Loading...